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FINAL EXAMINATION DURATION 
PHA311 – Clinical Biochemistry 
 
Reading Time: 10 minutes 
Writing Time: 180 minutes 
 
INSTRUCTIONS TO CANDIDATES 
The examination has TWO (A and B) Sections: 
  
Section A contains short essay questions: Answer All questions. Total marks allocated: Ninety (90). 
Suggested time allocation: Ninety (90) minutes  
 
Section B contains case studies questions: Answer All questions. Total marks allocated: Ninety (90). 




You may begin writing from the commencement of the examination session.  
The reading time indicated above is provided as a guide only. 
This is a CLOSED BOOK examination 
Any non-programmable calculator is permitted 
No handwritten notes are permitted 
No dictionaries are permitted 
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1 x 20 Page Book 
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Section A 
Short Essay Questions 
Total No of Marks for this section:  90 marks 
 
 
This section should be answered on the Answer Booklet provided.   
Please ensure that your name and student number have been written on the Answer 
Booklet. 
 
Marks for each question are indicated.  






a. List and describe the causes of variation in clinical laboratory test results. 
b. List and explain the properties of an ideal marker to distinguish health and 
disease in humans. 





a. Explain the difference between laboratory measured osmolality and calculated 
osmolality.  
b. Describe TWO clinical examples where a significant difference can be observed 






Discuss any FOUR of the following components of liver function testing. For each 
component, explain what information the test provides and use examples to illustrate 
your answers. 
 
a. Alkaline phosphatase (ALP) 
b. Alanine aminotransferase (ALT) 
c. Gamma glutamyl transpeptidase (GGT) 
d. Bilirubin 
e. Prothrombin time (PT) 
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Question 4 
 
Discuss the clinical application of any TWO of the following cardiac biomarkers. For 
each biomarker, explain what information the test provides and any observed 
limitations. Use examples to illustrate your answer. 
 









Discuss the common mechanisms which can lead to the following electrolyte 









A 45 year old patient presents for a routine checkup. He has no known medical 
conditions. He is not on any medication. He is a smoker and his father died of a heart 
attack aged 55. 
 
a. Comment on the following fasting serum lipid levels.  
Total Cholesterol   7.1 
LDL                        5.2 
HDL                       0.8 
Triglyceride            2.5 








Discuss any TWO creatinine based methods of assessing renal function. For each 






END OF SECTION  
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Section B 
Case Study Based Questions 
Total No of Marks for this section: 90 Marks 
 
This section should be answered in the Answer Booklet provided. 
 
Marks for each question are indicated.   








A 22 year old patient has had severe diarrhea for 3 days. He has become increasingly 
lethargic and complains of weakness. He does not have any other known medical 
conditions. 
His doctor orders the following blood tests: full blood examination (FBE), UEC, LFT, 
ABG. 
The results are shown below: 
 
U&E LFT FBE ABG 
Na 138 ALP 60 Hb 165 pH 7.29 
K  3.1 ALT 35 RCC 5.1 pCO2 26 
Cl 114 GGT 37 Hct 61% O2 92 
Urea  1.8 Bilirubin (total) 17 MCV 91 Bicarbonate 11 
Cr  100 Albumin  30 WCC 8.5  
AG 16  Platelet  395 
 
Considering the case and the results provided, answer the following questions: 
 
a. What do the ABG results indicate? 
 (10 Marks) 
 
b. What is the most likely cause of any abnormalities observed in the ABG results? 
 
 (2 Marks) 
 
c. Briefly describe 4 other conditions can cause the observed ABG results? 
 
 (8 Marks) 
 
d. Describe the factors that may have influenced the U/E results 
(5 Marks) 
 
e. What do the other laboratory results (LFT & FBE) indicate? 
 (5 Marks) 
 
 
(Total Marks: 30) 
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Case 2  
 
A 35 year old woman presented to her GP, complaining of fatigue, weight gain (6kg in 
the previous 3 months), and feeling excessively cold. She has also noticed that her 
monthly period has been heavier than usual. 
Some blood tests are ordered and the results are shown below: 
 
U&E LFT FBE Iron Studies TFT  
Na 139 ALP 45 Hb 80 Serum 
Iron 
4ug/L TSH 45 





Cl 106 GGT 34 Hct 28% TIBC 86ug/L Free 
T3 
2.3 
Urea  5.2 Bilirubin(total) 16 MCV 60 Serum 
Ferritin 
6ug/L  
Cr  98 Albumin  56 Reticulocytes 1.5%  
eGFR >90  WCC 6.6 
 Platelet  320 
 
 
Considering the case and results provided, answer the following questions: 
 
a. What do the TFT results indicate? 
(5 Marks) 
 




d. What do the FBE results indicate? 
(5 Marks) 
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A 50 year old man is admitted to hospital with septicaemia. He is unwell, dehydrated 
and only passing a small volume of urine (oliguria). 
 
His laboratory results are shown below: 
 
U&E LFT FBE Others 
Na 138 ALP 35 Hb 158 Blood glucose 5.6 
K  5.0 ALT 26 RCC 4.8  
Cl 98 AST 29 Hct 50% 
Bicarbonate 22 Bilirubin(total) 17 Platelet 160 
Urea  26 Albumin 33 MCV 88 
Cr  200  WCC 20 
AG 23   
 
Considering the case and results provided, answer the following questions: 
 
a. What do the U&E results indicate? 
 (5 Marks) 
 
b. What does the anion gap indicate? 
(5 Marks) 
 
c. What further tests would be appropriate? 
 (2 Marks) 
 
d. Calculate his plasma osmolality and what does this indicate? 
(8 Marks) 
 
e. Explain how the urine osmolality would compare to the plasma osmolality? 
 
 (10 Marks) 
 
(Total Marks 30) 





END OF SECTION B 
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Reference Ranges  
 
Urea and electrolytes (U&E) 
Na 135.0-145.0 mmol/L 
K 3.50-4.50 mmol/L (plasma)   
3.8-4.9 mmol/L (serum) 
Cl 95-110 mmol/L 
Urea 3.8-8.0 mmol/L 
Creatinine 60-100 micromol/L 
eGFR > 90 mL/min/1.73 m2 
Osmolality (serum) 275-295 mOsm/kg 
Anion gap 13-17 mEq/L 
 
Calcium, magnesium and phosphate (CMP) 
Ca (total) 2.1-2.6 mmol/L 
Ca (ionised) 1.16-1.3 mmol/L 
PO43- 0.8-1.5 mmol/L 
Mg 0.8-1.0 mmol/L 
 
Arterial blood gas (ABG) 
pH 7.35-7.45 
pO2 80-110 mmHg 
pCO2 35-45 mmHg 
Bicarbonate (HCO3-) 22-33 mmol/L 
 
 
Liver function test (LFT) 
ALT <30 U/L 
AST <40 U/L 
ALP 30-100 U/L 
GGT <30 U/L (female) 
<50 U/L (male) 
Bilirubin (total) <20 umol/L 
Bilirubin (conjugated) <4.0 umol/L 
Albumin 32-45 g/L 
Total protein 63-80 g/L 
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Full blood examination (FBE) 
Hb 140-174 g/L (male) 
120-160 g/L (female)  
RCC 4.50-5.50 x1012/L (male) 
4.0- 5.0 x1012/L (female)  
Haematocrit 0.42-0.52 or 42-52 % (male) 
0.36-0.48 or 36-48%(female) 
MCV 80.0-100.0 fL 
RDW 11.5-14.5 % 
Platelets 150-450 x109/L) 
WCC 4.0-11.0 (x109 /L) 
Neutrophil 40-80% 
2.0-7.5 x109 /L 
Lymphocytes 20-40% 




0.0-0.4 x109 /L 
Basophils <2% 
0.0-0.1 x109 /L 
 
Thyroid function test (TFT) 
TSH 0.4-5.0 mU/L 
T4 (free) 10-25 pmol/ 
T3 (free) 3.0-6.5 pmol/L 
 
Carbohydrate metabolism 
BSL (random) 3.0-7.7 mmol/L 
BSL (fasting) 3.0-5.5 mmol/L 
HbA1c(non-DM) 4.3-5.7% (NGSP) 
23-39 mmol/mol (IFCC) 
HbA1c (DM) therapeutic target<7% * 
 
Fasting lipid biochemistry 
Total cholesterol <5.5 mmol/L 
LDL 2-3.4 mmol/L 
HDL >1 mmol/L 
Non-HDL cholesterol <2.5 mmol/L 
TG <1.7 mmol/L 
 
Others 
Troponin T <0.01 μg/L 
CRP <3 mg/L 
D-dimer <500 μg/L 
BNP <20 nmol/L 
 
 
